Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was applied, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding lapse notice and the previous Revision: v3.4.1. These changes pertain to site maintenance banners and do not affect study details.
    Difference
    0.4%
    Check dated 2026-02-11T12:38:23.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice was added to the top of the page and the revision label changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T07:35:08.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include a Show glossary toggle and new study-record dates such as Results First Posted, Last Update Submitted that Met QC Criteria, and Last Update Posted, along with a revision notice (v3.4.0). Older labels and data points (Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) were removed or renamed.
    Difference
    0.3%
    Check dated 2026-01-28T05:13:26.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T01:50:33.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Illinois, Michigan, New York, and North Carolina, replacing the previous separate state location subsections; removed the state-specific location subsections and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T09:59:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.